STAT Virtual Event | Cancer’s Breakthrough Engine
Join STAT’s Adam Feuerstein and a panel of experts for a Dec. 19 virtual event that will cover the hottest new approaches in precision cancer medicines.
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET.
Since the development of Gleevec two decades ago, precision cancer medicines have become a driving force in biotech and a source of hope for cancer patients.
What's Your Reaction?
